Literature DB >> 9714542

Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters.

C J Hastie1, P T Cohen.   

Abstract

Protein phosphatase 4 (PP4) is a protein serine/threonine phosphatase that predominantly localises to centrosomes and plays a role in microtubule organisation at centrosomes. Here, PP4 catalytic subunit has been purified from porcine testis to near homogeneity and a specific activity of 680 mU/mg against phosphorylase alpha. The antitumour drug, fostriecin, inhibits PP4 catalytic subunit (IC50 3 nM) with similar potency to PP2A catalytic subunit (IC50 1.5 nM). PP4 is also inhibited in the nanomolar range by several naturally occurring tumour promoters and toxins, with similar IC50 values to those obtained for PP2A. The gene for human PP4 catalytic subunit localises to 16p11.2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714542     DOI: 10.1016/s0014-5793(98)00775-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits.

Authors:  Adam M Silverstein; Christina A Barrow; Anthony J Davis; Marc C Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Authors:  Shaofan Weng; Hua Wang; Weihong Chen; Matthew H Katz; Deyali Chatterjee; Jeffrey E Lee; Peter W Pisters; Henry F Gomez; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

3.  Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibition.

Authors:  Brian G Lawhorn; Sobhana B Boga; Scott E Wolkenberg; David A Colby; Carla-Maria Gauss; Mark R Swingle; Lauren Amable; Richard E Honkanen; Dale L Boger
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

Review 4.  Synthetic Strategies Employed for the Construction of Fostriecin and Related Natural Products.

Authors:  Barry M Trost; Joshua D Knopf; Cheyenne S Brindle
Journal:  Chem Rev       Date:  2016-12-08       Impact factor: 60.622

Review 5.  The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.

Authors:  A Rietz; Jp Spiers
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  Protein phosphatase 2A dephosphorylates CaBP4 and regulates CaBP4 function.

Authors:  Françoise Haeseleer; Izabela Sokal; Frederick D Gregory; Amy Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

7.  Functional analysis of the PP2A subfamily of protein phosphatases in regulating Drosophila S6 kinase.

Authors:  Vincent A Bielinski; Marc C Mumby
Journal:  Exp Cell Res       Date:  2007-05-16       Impact factor: 3.905

8.  The methyl ester of okadaic acid is more potent than okadaic acid in disrupting the actin cytoskeleton and metabolism of primary cultured hepatocytes.

Authors:  Begoña Espiña; M Carmen Louzao; Eva Cagide; Amparo Alfonso; Mercedes R Vieytes; Takeshi Yasumoto; Luis M Botana
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

9.  Protein phosphatase 2A is a negative regulator of transforming growth factor-beta1-induced TAK1 activation in mesangial cells.

Authors:  Sung Il Kim; Joon Hyeok Kwak; Lin Wang; Mary E Choi
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

10.  Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells.

Authors:  Mirna Mourtada-Maarabouni; Gwyn T Williams
Journal:  Leuk Res       Date:  2009-06-18       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.